Monday, April 22nd:

Upgrades

• Alcoa (AA)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Underweight >> Equal-Weight
  • Price Target: $28.5 >> $36.5
• CytomX Therapeutics (CTMX)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Underweight >> Neutral
• Euronet (EEFT)
  • Brokerage Firm: Citigroup
  • Ratings Change: Neutral >> Buy
  • Price Target: $116 >> $120
• Equity Residential (EQR)
  • Brokerage Firm: BMO Capital Markets
  • Ratings Change: Market Perform >> Outperform
  • Price Target: $68 >> $70
• Federal Realty (FRT)
  • Brokerage Firm: Deutsche Bank
  • Ratings Change: Hold >> Buy
  • Price Target: $109 >> $110
• L3Harris (LHX)
  • Brokerage Firm: Alembic Global Advisors
  • Ratings Change: Neutral >> Overweight
  • Price Target: $238
• Ingevity (NGVT)
  • Brokerage Firm: Jefferies
  • Ratings Change: Hold >> Buy
  • Price Target: $52 >> $62
• Northrop Grumman (NOC)
  • Brokerage Firm: Alembic Global Advisors
  • Ratings Change: Neutral >> Overweight
  • Price Target: $532
• Provident Financial (PFS)
  • Brokerage Firm: DA Davidson
  • Ratings Change: Neutral >> Buy
  • Price Target: $15 >> $20
• Papa John’s (PZZA)
  • Brokerage Firm: Stifel
  • Ratings Change: Sell >> Hold
  • Price Target: $65 >> $60
• Robert Half (RHI)
  • Brokerage Firm: Truist
  • Ratings Change: Sell >> Hold
  • Price Target: $72
• Sea Limited (SE)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Neutral >> Buy
  • Price Target: $62 >> $70
• PPG Industries (PPG)
  • Brokerage Firm: Seaport Research Partners
  • Ratings Change: Neutral >> Buy
• Sea Limited (SE)
  • Brokerage Firm: Morgan Stanley
  • Ratings Change: Equal-Weight >> Overweight
  • Price Target: $65 >> $70

Downgrades

• CNH Industrial (CNHI)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Buy >> Neutral
• CVB Financial (CVBF)
  • Brokerage Firm: Hovde Group
  • Ratings Change: Outperform >> Market Perform
  • Price Target: $18
• OGE Energy (OGE)
  • Brokerage Firm: Barclays
  • Ratings Change: Overweight >> Equal Weight
  • Price Target: $34
• Pacific Biosciences (PACB)
  • Brokerage Firm: JP Morgan
  • Ratings Change: Overweight >> Neutral
• Prologis (PLD)
  • Brokerage Firm: BMO Capital Markets
  • Ratings Change: Outperform >> Market Perform
  • Price Target: $145 >> $112
• PPG Industries (PPG)
  • Brokerage Firm: Evercore ISI
  • Ratings Change: Outperform >> In-line
  • Price Target: $152
• UBS AG (UBS)
  • Brokerage Firm: Exane BNP Paribas
  • Ratings Change: Outperform >> Neutral
• Western Digital (WDC)
  • Brokerage Firm: Raymond James
  • Ratings Change: Outperform >> Mkt Perform
• Southern Copper (SCCO)
  • Brokerage Firm: HSBC Securities
  • Ratings Change: Hold >> Reduce
  • Price Target: $80

Coverage Initiated

• Agilon Health (AGL)
  • Brokerage Firm: Citigroup
  • Ratings Change: Neutral
  • Price Target: $6
• Boundless Bio (BOLD)
  • Brokerage Firms: Leerink Partners, Guggenheim, Piper Sandler
  • Ratings Change: Outperform, Buy, Overweight
  • Price Targets: $25, $24, $20
• BellRing Brands (BRBR)
  • Brokerage Firm: TD Cowen
  • Ratings Change: Buy
  • Price Target: $64
• Cardiol Therapeutics (CRDL)
  • Brokerage Firm: H.C. Wainwright
  • Ratings Change: Buy
  • Price Target: $9
• EastGroup (EGP)
  • Brokerage Firm: BMO Capital Markets
  • Ratings Change: Outperform
  • Price Target: $190
• enGene Holdings (ENGN)
  • Brokerage Firm: Wells Fargo
  • Ratings Change: Overweight
  • Price Target: $30
• Evolent Health (EVH)
  • Brokerage Firm: Citigroup
  • Ratings Change: Buy
  • Price Target: $40
• GE Vernova (GEV)
  • Brokerage Firm: Melius
  • Ratings Change: Hold
  • Price Target: $147
• Hut 8 Mining (HUT)
  • Brokerage Firm: The Benchmark Company
  • Ratings Change: Buy
  • Price Target: $12
• Kirby (KEX)
  • Brokerage Firm: Wolfe Research
  • Ratings Change: Outperform
  • Price Target: $126
• Kinetik (KNTK)
  • Brokerage Firm: Barclays
  • Ratings Change: Equal Weight
  • Price Target: $40
• Madrigal Pharmaceuticals (MDGL)
  • Brokerage Firm: BofA Securities
  • Ratings Change: Underperform
  • Price Target: $150
• Privia Health (PRVA)
  • Brokerage Firm: Citigroup
  • Ratings Change: Buy
  • Price Target: $25
• Palmer Square Capital BDC (PSBD)
  • Brokerage Firm: Janney
  • Ratings Change: Neutral
  • Price Target: $17.5
• Ultragenyx Pharma (RARE)
  • Brokerage Firm: RBC Capital Mkts
  • Ratings Change: Outperform
  • Price Target: $77

trading, trading adalah, trading view, trading forex, robot trading, apa itu trading, trading saham, belajar trading, trading crypto

#Analyst #Upgrades #Downgrades #Week #April #22nd